B. N. Bekele and P. F. Thall, Dose-finding based on multiple toxicities in a soft tissue sarcoma trial, Journal of the American Statistical Association, vol.99, pp.26-35, 2004.

T. M. Braun, P. F. Thall, H. Nguyen, and M. De-lima, Simultaneously optimizing dose and schedule of a new cytotoxic agent, Clinical Trials, vol.4, pp.113-124, 2007.

T. M. Braun, Z. Yuan, and P. F. Thall, Determining a maximum-tolerated schedule of a cytotoxic agent, Biometrics, vol.61, pp.335-343, 2005.

B. Cheng and S. M. Lee, On the consistency of the continual reassessment method with multiple toxicity constraints, Journal of Statistical Planning and Inference, vol.164, pp.1-9, 2015.

Y. K. Cheung, dfcrm: Dose-Finding by the Continual Reassessment Method, 2013.

Y. K. Cheung, Simple benchmark for complex dose finding studies, Biometrics, vol.70, pp.389-397, 2014.

Y. K. Cheung and R. Chappell, Sequential designs for phase i clinical trials with late-onset toxicities, Biometrics, vol.56, pp.1177-1182, 2000.

A. Doussau, R. Thiébaut, and X. Paoletti, Dose-finding design using mixed-effect proportional odds model for longitudinal graded toxicity data in phase i oncology clinical trials, Statistics in Medicine, vol.32, pp.5430-5447, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00936325

M. Ezzalfani, S. Zohar, R. Qin, S. J. Mandrekar, and M. C. Deley, Dose-finding designs using a novel quasi-continuous endpoint for multiple toxicities, Statistics in Medicine, vol.32, pp.2728-2746, 2013.

A. Ivanova and S. H. Kim, Dose finding for continuous and ordinal outcomes with a monotone objective function: a unified approach, Biometrics, vol.65, pp.307-315, 2009.

S. M. Lee and Y. K. Cheung, Model calibration in the continual reassessment method, Clinical Trials, vol.6, pp.227-238, 2009.

S. M. Lee, D. Backenroth, Y. K. Cheung, D. L. Hershman, D. Vulih et al., Case example of dose optimization using data from Bortezomib dose-finding clinical trials, Journal of Clinical Oncology, vol.34, pp.1395-1401, 2016.

S. M. Lee, B. Cheng, and Y. K. Cheung, Continual reassessment method with multiple toxicity constraints, Biostatistics, vol.12, pp.386-398, 2011.

S. M. Lee, D. L. Hershman, P. Martin, J. P. Leonard, and Y. K. Cheung, Toxicity burden score: a novel approach to summarize multiple toxic effects, Annals of Oncology, vol.23, pp.537-541, 2012.

C. A. Liu and T. M. Braun, Parametric non-mixture cure models for schedule finding of therapeutic agents, Journal of the Royal Statistical Society: Series C (Applied Statistics), vol.58, pp.225-236, 2009.

K. Margolin, T. Synold, J. Longmate, and J. H. Doroshow, Methodologic guidelines for the design of high-dose chemotherapy regimens, Biology of Blood and Marrow Transplantation, vol.7, pp.414-432, 2001.

. National-cancer-institute, Common Terminology Criteria for Adverse Events (CTCAE). Version 4.0. Bethesda, Maryland: National Institutes of Health, 2009.

J. O'quigley, M. Pepe, and L. Fisher, Continual reassessment method: a practical design for phase i clinical trials in cancer, Biometrics, vol.46, pp.33-48, 1990.

X. Paoletti, A. Doussau, M. Ezzalfani, E. Rizzo, and R. Thiebaut, Dose finding with longitudinal data: simpler models, richer outcomes, Statistics in Medicine, vol.34, pp.2983-2998, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01288874

R. Core-team, R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing, 2013.

M. Ranson, M. Reck, A. Anthoney, A. R. Hanauske, E. Dean et al., Erlotinib in combination with pemetrexed for patients with advanced non-small-cell lung cancer (NSCLC): a phase I dose-finding study, Annals of Oncology, vol.21, pp.2233-2239, 2010.

B. E. Storer, Design and analysis of phase I clinical trials, Biometrics, vol.45, pp.925-937, 1989.

E. M. Van-meter, E. Garrett-mayer, and D. Bandyopadhyay, Proportional odds model for dose-finding clinical trial designs with ordinal toxicity grading, Statistics in Medicine, vol.30, pp.2070-2080, 2011.

E. M. Van-meter, E. Garrett-mayer, and D. Bandyopadhyay, Dose-finding clinical trial design for ordinal toxicity grades using the continuation ratio model: an extension of the continual reassessment method, Clinical Trials, vol.9, pp.303-313, 2012.

Z. Yuan, R. Chappell, and H. Bailey, The continual reassessment method for multiple toxicity grades: a Bayesian quasi-likelihood approach, Biometrics, vol.63, pp.173-179, 2007.